1995
Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy
Wilson L, Licata A, Braverman I, Edelson R, Heald P, Feldman A, Kacinski B. Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy. International Journal Of Radiation Oncology • Biology • Physics 1995, 32: 987-995. PMID: 7607973, DOI: 10.1016/0360-3016(95)00073-8.Peer-Reviewed Original ResearchConceptsTotal skin electron beam therapyDoxorubicin/cyclophosphamideCutaneous T-cell lymphoma patientsAdjuvant doxorubicin/cyclophosphamideT-cell lymphoma patientsExtracorporeal photochemotherapyComplete responseOverall survivalAdjuvant therapyElectron beam therapyAdjuvant regimenFree survivalCTCL patientsLymphoma patientsBeam therapyAddition of chemotherapyAdvanced stage CTCLClinical complete responseSystemic adjuvant therapyGood partial responseSignificant survival benefitBetter overall survivalRelapse-free survivalSoles of feetNontoxic regimen
1994
Novel prognostic factors predictive of prolonged relapse-free and overall survival in advanced stage CTCL (mycosis fungoides) patients treated with total skin electron beam therapy
Kacinski B, Wilson L, Quiros P, Kolenik S, Heald P, Edelson R, Braverman I. Novel prognostic factors predictive of prolonged relapse-free and overall survival in advanced stage CTCL (mycosis fungoides) patients treated with total skin electron beam therapy. International Journal Of Radiation Oncology • Biology • Physics 1994, 30: 268. DOI: 10.1016/0360-3016(94)90823-0.Peer-Reviewed Original Research
1992
The role of novel prognostic factors & adjuvant therapy in CTCL (Mycosis fungoides) patients treated with total skin electron beam therapy
Kacinski B, Murren J, Friedman N, Braverman I, Cooper D. The role of novel prognostic factors & adjuvant therapy in CTCL (Mycosis fungoides) patients treated with total skin electron beam therapy. International Journal Of Radiation Oncology • Biology • Physics 1992, 24: 229. DOI: 10.1016/0360-3016(92)90308-5.Peer-Reviewed Original Research
1991
Repeat courses of either total skin electron beam therapy (TSEBT) or local RT are safe and effective palliation to relapsed CTCL patients whose symptoms are not controlled by other topical or systemic anti-ctcl therapies
Kacinski B, Friedrtan N, Murren J, Cooper D, Braverman I. Repeat courses of either total skin electron beam therapy (TSEBT) or local RT are safe and effective palliation to relapsed CTCL patients whose symptoms are not controlled by other topical or systemic anti-ctcl therapies. International Journal Of Radiation Oncology • Biology • Physics 1991, 21: 212. DOI: 10.1016/0360-3016(91)90608-7.Peer-Reviewed Original Research